Here’s what we know so far COVID vaccines for 5 to 11 year olds are inching closer.

COVID vaccines


Australian children aged five to 11 could begin receiving the Pfizer vaccine with the nation’s regulator currently reviewing the health and safety data at the end of November.

Therapeutic Goods Administration (TGA) this week and will supply the remaining data over the next two weeks. all the information and make a decision about whether to approve Pfizer submitted a partial application to Australia’s  The TGA will then review the vaccine for use in this age group.

Barring any issues, The Australian Technical Advisory Group on Immunisation (ATAGI), TGA head John Skerritt expects a decision will be made by the end of November. will then advise the government on the timing of the rollout.

And what are the benefits of vaccinating children aged five to 11? So what does the data say so far on safety and efficacy?

Why vaccinate children?

While the risk of severe COVID in children is low, and some of them will die from the virus. a small proportion of children who are infected will become severely unwell.

As Delta case numbers rise, In the United States, children represented more than six million (16.4%) of the total COVID reported cases (8,208 cases per 100,000 children). so too will the number of serious cases and fatalities. More than 23,582 US children have been hospitalized and 558 children died (0.01% of child COVID cases).

 

 

Multi-system inflammatory  (MIS-C) has been reported in children following COVID infection. This can cause multiple parts of the body to the lungs, eyes, brain, kidneys, become inflamed, including the heart, skin, and gastrointestinal system.

with a median patient age of nine years; 46 children have died from the condition.

 Since May 2020, 5,217 cases of MIS-C have been reported in the United States, although MIS-C can be serious, Thankfully, most children who are diagnosed with MIS-C recover with medical care.

Here’s what we know so far COVID vaccines for 5 to 11 year olds are inching closer.
Here’s what we know so far COVID vaccines for 5 to 11-year-olds are inching closer.

In adults, even mild infection can cause a range of ongoing symptoms of long COVID. The long term effects of COVID are still unknown. joint and muscle pain, loss of smell, These include fatigue, chest pain and problems with memory, shortness of breath, concentration, and sleep.

Data from the other research suggests they rarely last more than 12 weeks. UK found 9.8% of children aged 2–11 years reported at least one long COVID symptom five weeks after.

However, a quarter of children discharged from hospital had symptoms more than five months later data from Russia which is yet to be peer-reviewed found one.

This is of concern, Even if a small proportion of children have long-term symptoms, and further studies are required.

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *